Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This study proposes to examine the potential safety and efficacy of ziprasidone for patients
with anxiety and bipolar disorder on anxiety outcomes, bipolar symptoms, and on measures of
quality of life and resilience.